CoreWeave vs Immunovant Inc. Common Stock — how do they compare? CoreWeave trades at $83.52 (market cap $48.78B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: CoreWeave is far larger — about 7.4× Immunovant Inc. Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, CoreWeave nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold CoreWeave for 6 Days and Immunovant Inc. Common Stock for 0 Days on average.
| CRWV | IMVT | |
|---|---|---|
Market Cap | $48.78B | $6.62B |
Volume | 19,704,178 | 1,131,364 |
Sector | Technology | Health |
52-Week High | $143.08 | $44.96 |
52-Week Low | $60.82 | $17.03 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $94.85B | $5.72B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
CoreWeave provides cloud computing infrastructure designed for AI workloads. Its platform gives organizations access to large-scale GPU computing and cloud services for training and running AI models.
Read more on CRWV →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →